buy cialis super active online
Sunday, July 22, the Coalition for a National AIDS Strategy hosted the AIDS 2012 conference satellite “From Revolution to Reality: How Will New Science Impact the U.S. National HIV/AIDS Strategy?”, supported by Bristol-Myers Squibb (with no editorial discretion over content).
We have a few take-aways from the session:
- Despite the FDA’s recent approval of an HIV medication for PrEP, it will be a while before PrEP is widely used and has an impact on the epidemic. There are still more questions than answers. .
- There are just as many questions about the role of antiretroviral-based HIV prevention strategies, from PrEP to treatment as prevention to microbicides. Molly Morgan Jones and the Mapping Pathways team gave an excellent gathering insights from across the globe on expert attitudes towards ARV-base prevention.
- Dr. Carlos del Rio's touched on the challenges of engaging people in care and retaining them in care. The “social determinants of treatment” – substance abuse and mental health treatment, housing, and transportation – are critical to engagement in care. Although there is a debate on when to start treatment (as soon as someone is diagnosed, or based on immune system health), it’s largely irrelevant because when most people are diagnosed, their CD4 count is already so low that they need treatment. Dr. del Rio noted that there are no evidence-based programs to retain people in care (although some federally-funded studies may soon show results). And finally, we will have no ability to measure progress towards the NHAS goals until we implement the IOM monitoring report.
- Dr. David Holtgrave in his highlighted his recent paper analyzing if it is still possible to achieve the goals of the NHAS. A combination of testing, expansion, care expansion, and prevention with positives would be the most cost-effective mix of interventions. The good news, however, is that based on the epidemiology, it’s possible to reach these goals with an investment of $13-$17 billion in new resources would be needed, starting in October 2012 (the beginning for federal fiscal year 2013).
For advocates who press government leaders for new resources, Holtgrave’s is a roadmap for the arguments we need to make to elected officials. He tells us how much funding is needed and how it should be spent. Now it’s our jobs to deliver the message to our elected officials that progress against HIV/AIDS is possible - through events like AIDS United's. No one else is going to do it for us.
buy cialis super active online
If you're coming to the AIDS 2012 conference later this month, add this great session to your agenda! Hear from HIV/AIDS advocates from all over the country and learn how actions taken by the Congress and the Obama administration are impacting implementation of the Strategy.
buy cialis super active online AIDS in America
buy cialis super active online “Achieving the Goals of the U.S. National HIV/AIDS Strategy: A Community Perspective”
buy cialis super active online Thursday, July 26, 6:30 p.m. – 8:30 p.m.
buy cialis super active online Walter E. Washington Convention Center, Mini Room 10 Washington, DC, Session ID number: 1519
buy cialis super active online
Discussion will focus on:
• availability of resources to carry out prevention, care, treatment and research programs
• policy positions on issues including health care reform and the ability to carry out scientific-based prevention programs
• the needs of specific populations most impacted by HIV and if they are being addressed
• the role of the private sector and philanthropy in achieving the goals of the Strategy
• potential obstacles that can derail implementation of the Strategy
• suggestions on how the goals can be achieved
buy cialis super active online
In the past couple of weeks, U.S. Representatives buy cialis super active online (D-IL) and buy cialis super active online (D-CA) have been circulating a dear-colleague letter in the House, inviting members of Congress to support them in requesting an official, unbiased estimate from the Congressional Budget Office of the needed investments and corresponding savings of a fully implemented National HIV/AIDS Strategy.
Thanks to your efforts, 40 cosigners have joined the letter! You can view the letter to see if your Representative signed on. If so, call him or her to say "Thank you for signing on to the Quigley/Lee letter requesting a cost/savings estimate for implementation of the National HIV/AIDS Strategy."
buy cialis super active online
Ronald Johnson, Deputy Executive Director of , delivered a rousing speech at the HIV/AIDS Rally & Vigil at the (held over the weekend of October 10-11, 2009). The march marked the first time in nearly ten years that lesbian, gay, bisexual, transgender Americans and their allies converged on our nation's capital from around the country to advocate for their rights.
Amidst calls for pro-equality measures long left sitting on Congress's shelves, Johnson's speech highlighted a recent success of HIV/AIDS activists, including many LGBT activists: President Obama's commitment to creating a National AIDS Strategy through the .
The call to action now, Johnson said, is ensuring that the process for creating the strategy meets to goals of the framework hundreds of organizations and thousands of individuals contributed to creating through the .
Click below to read his speech in full.
buy cialis super active online
As Congress continues to consider legislation to remove the federal ban on syringe exchange funding, the Coalition for a National AIDS Strategy called on President Obama to take a leadership role, pushing Congress to send him a bill this year.
The letter was delivered to the President on October 9, 2009. The full text is below:
Dear Mr. President,
Thank you for your commitment to developing and implementing a National HIV/AIDS Strategy (NHAS) for the United States. We are among the 500 organizations and 2,400 individuals who signed the Call to Action for a NHAS and who, for the past several years, have been advocating for a more coordinated, accountable and outcomes-oriented approach to HIV/AIDS in the United States through a NHAS.
As organizations and individuals committed to an evidence-based, effective HIV prevention effort, we also understand the urgency of removing the ban on federal funds for syringe exchange programs (SEPs). As you know, numerous federally funded studies have found that SEPs reduce HIV and hepatitis C incidence without increasing drug use or crime. Yet lack of resources makes it impossible for SEPs around the country to meet communities’ needs for the essential prevention, treatment and other services these programs provide. The challenge is particularly acute as states across the country grapple with fiscal shortfalls by reducing state funding for vital HIV/AIDS prevention programming, including SEPs.
Earlier this year, you reaffirmed your support for removing the ban on federal funding for SEPs and indicated you want to eliminate the ban as part of the NHAS process. We are writing to let you know that efforts to remove the SEPs ban cannot wait until completion of your Administration’s NHAS.
(Click below to read the rest.)